Missouri Board of Pharmacy Update

Updated COVID-19 Vaccine

On September 11, 2023, the U.S. Food and Drug Administration (FDA) announced the following action:

Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Consistent with the totality of the evidence and input from the FDA’s expert advisors, these vaccines have been updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5.  (See FDA announcement at:  https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating)

Pursuant to recently revised section 338.010.1(4), pharmacists may administer the updated COVID-19 vaccines referenced above independently or by physician protocol, if authorized by your governing protocol.  Effective August 28, 2023, a physician protocol is optional and is no longer required.   See also emergency rule 20 CSR 2220-6.050 which clarifies pharmacists may administer reformulated or updated versions of vaccines authorized by the U.S. Food and Drug Administration (FDA) after January 1, 2023, provided the initial vaccine was approved by the FDA prior to January 1, 2023.

Pharmacists immunizing under 338.010.1(4) must have a Notification of Intent to immunize on file with the Board and meet the requirements of rule 20 CSR 2220-6.050. Pharmacists immunizing under the PREP Act authority must comply with all requirements of the PREP Act.   (COVID-19 vaccines may also be administered by prescription order pursuant to 20 CSR 2220-6.040).

BNDD September 2023 Newsletter

The Bureau of Narcotics and Dangerous Drugs (BNDD) September 2023 newsletter is available here.

Registration Is Now Open for the Next 'Lunch with the Chief Inspector' Webinar

 A compliance update with an extended question and answer session.

 Date: Thursday, September 21, 2023

Time: 12 Noon - 1 PM CDT

Cost: Free

Subject: Compliance Update/Question & Answer Session

Speakers:

Tom Glenski, R.Ph. – Chief Inspector

Click here to register for the webinar.

Please submit your questions for the question & answer session in advance to compliance@pr.mo.gov using the subject: "Webinar Question".

This webinar has been approved for one hour of continuing education (CE) by the Missouri Board of Pharmacy.

To receive CE credit, persons must individually register for the program and individually log in to the webinar.  CE credit will not be issued for those listening via telephone only.

Handouts will be available on the Board's website the day of webinar.